+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Asia-Pacific Vascular Grafts Market Outlook to 2036 - Aortic Vascular Grafts and Peripheral Vascular Grafts

  • PDF Icon

    Report

  • 75 Pages
  • April 2026
  • Region: Asia Pacific
  • GlobalData
  • ID: 5987306
The “Asia-Pacific Vascular Grafts Outlook to 2036” is a comprehensive databook report, covering key market data on the Asia-Pacific Vascular Grafts market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Aortic Vascular Grafts and Peripheral Vascular Grafts

The Asia-Pacific Vascular Grafts Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
  • 2025 company share data for Vascular Grafts Market.
  • Global corporate-level profiles of key companies operating within the Asia-Pacific Vascular Grafts Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

Asia-Pacific Vascular Grafts is segmented as follows:

  • Aortic Vascular Grafts
  • Peripheral Vascular Grafts

Reasons to Buy

The Asia-Pacific Vascular Grafts Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Introduction
1.1 What Is This Report About?
1.2 Vascular Grafts Market Segmentation
1.3 Definitions of Markets Covered in the Report
2 Vascular Grafts Market, United States
2.1 Vascular Grafts Market, United States, Revenue ($m), 2024-2036
2.2 Vascular Grafts Market, United States, Volume (Units), 2024-2036
2.3 Vascular Grafts Market, United States, Average Price ($), 2024-2036
2.4 Vascular Grafts Market, United States, Company Share by Revenue ($m), 2025
3 Vascular Grafts Market Pipeline Products
3.1 Vascular Grafts Market Pipeline Products
3.2 Vascular Grafts - Pipeline Products by Stage of Development
3.3 Vascular Grafts - Pipeline Products by Segment
3.4 Vascular Grafts - Pipeline Products by Territory
3.5 Vascular Grafts - Pipeline Products by Regulatory Path
3.6 Vascular Grafts - Pipeline Products by Estimated Approval Date
4 Overview of Key Companies in United States, Vascular Grafts Market
4.1 W. L. Gore & Associates Inc
4.1.1 Company Overview
4.2 CR Bard Inc
4.2.1 Company Overview
4.3 Terumo Corp
4.3.1 Company Overview
4.4 Artivion Inc
4.4.1 Company Overview
4.5 LeMaitre Vascular Inc
4.5.1 Company Overview
4.6 Getinge AB
4.6.1 Company Overview
5 Recent Developments
5.1 Corporate Communications
5.1.1 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
5.1.2 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
5.2 Financial Announcements
5.2.1 Sep 02, 2025: Boston Scientific Announces 2025 Investor Day Meeting and Conference Call Discussing Third Quarter 2025 Results
5.3 Government and Public Interest
5.3.1 Mar 03, 2026: Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference
5.3.2 Feb 27, 2026: LeMaitre to Participate at Upcoming Investor Conferences in March
5.3.3 Nov 03, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
5.3.4 Jul 30, 2025: Artivion to Participate in Upcoming Investor Conferences
5.3.5 May 01, 2025: Boston Scientific Announces Upcoming Investor Conference Schedule
5.4 Product News
5.4.1 Oct 30, 2025: VentureMed Group Closes $28 Million Series C Financing to Accelerate Commercial Adoption and Expand Indications for FLEX VPTM System
5.4.2 Oct 30, 2025: Humacyte Publishes New Data Comparing Symvess to Autologous Vein in Extremity Arterial Trauma
5.4.3 Oct 29, 2025: VentureMed Group Secures $28M Series C Funding to Boost FLEX VPTM System Adoption
6 Appendix
6.1 Research Methodology
6.1.1 Coverage
6.1.2 Secondary Research
6.1.3 Primary Research
6.1.4 Market Modeling and Forecasting
6.1.5 Company Share Analysis
6.1.6 Benchmarking
6.2 the analyst Consulting
6.3 Contact the Publisher
6.4 Disclaimer
List of Tables
Table 1: Vascular Grafts Market, United States, Revenue ($m), USD Constant, 2024-2036
Table 2: Vascular Grafts Market, United States, Volume (Units), 2024-2036
Table 3: Vascular Grafts Market, United States, Average Price ($), 2024-2036
Table 4: Vascular Grafts Market, United States, Company Share by Revenue ($m), USD Constant, 2025
Table 5: Vascular Grafts Market Pipeline Products
Table 6: Vascular Grafts - Pipeline Products by Stage of Development
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development
Table 8: Vascular Grafts - Pipeline Products by Segment
Table 9: Vascular Grafts - Pipeline Products by Territory
Table 10: Vascular Grafts - Pipeline Products by Regulatory Path
Table 11: Vascular Grafts - Pipeline Products by Estimated Approval Date
Table 12: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figures
Figure 1: Vascular Grafts Market, United States, Revenue ($m), USD Constant, 2024-2036
Figure 2: Vascular Grafts Market, United States, Volume (Units), 2024-2036
Figure 3: Vascular Grafts Market, United States, Company Share (%), 2025
Figure 4: Vascular Grafts - Pipeline Products by Stage of Development
Figure 5: Vascular Grafts - Pipeline Products by Segment
Figure 6: Vascular Grafts - Pipeline Products by Territory
Figure 7: Vascular Grafts - Pipeline Products by Regulatory Path
Figure 8: Vascular Grafts - Pipeline Products by Estimated Approval Date

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • W. L. Gore & Associates Inc
  • Terumo Corp
  • CR Bard Inc
  • Getinge AB
  • LeMaitre Vascular Inc